$70.45
-0.350 (-0.494%)
At Close: Jun 23, 2026
Gemini Therapeutics to Participate in the SVB Leerink 10th Annual Global Healthcare Conference
07:00am, Friday, 19'th Feb 2021
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Gemini Therapeutics, Inc. (Nasdaq: GMTX), a clinical stage precision medicine company developing innovative treatments for genetically defined age-related macular de
3 of the Latest Companies to Go Public Via SPACs
01:21pm, Wednesday, 17'th Feb 2021
SPACs dominated Wall Street in 2020. The backwards IPOs of these three companies suggests that 2021 will be more of the same.
Sign In
Buy IRON